Anthem Biosciences News
- Market cap
- ₹49,765 crore
- P/E
- 86.4
- P/B
- 16.36
- ROE
- 21.7%
- Dividend yield
- 0.23%
The latest update on Anthem Biosciences is "ANTHEM Reports Quarterly Financial Results & Operating Metrics Update" (BSE Corporate Announcement), published 7 October 2026. This page lists 4 recent headlines and exchange announcements, 2 of them filed on BSE.
Latest Anthem Biosciences news and announcements
Source: Publisher headlines and announcements filed on BSE, linked to their original sources. Data as of 7 October 2026. How this data is compiled.
Anthem Biosciences news & announcements — frequently asked questions
What is the latest news on Anthem Biosciences?
The most recent item is "ANTHEM Reports Quarterly Financial Results & Operating Metrics Update" from BSE Corporate Announcement on 7 October 2026. The full list above links to each original source.
Where do these Anthem Biosciences headlines come from?
Headlines link to the original publisher, and exchange announcements link to the filing on BSE. ATS lists them by date and does not rewrite or summarise them.
Same Data For Peers
- Sun Pharmaceutical Industries Limited news & announcements
- Divi's Laboratories Limited news & announcements
- Torrent Pharmaceuticals Limited news & announcements
- Zydus Lifesciences Limited news & announcements
- Apollo Hospitals Enterprise Limited news & announcements
- Laurus Labs Limited news & announcements
Trade Anthem Biosciences With ATS
Track ANTHEM live and place orders from the Pocket app or the Pocket Web terminal with an ATS trading and demat account.
Figures are for information only and are not investment advice or a recommendation to buy, sell or hold any security. Investments in securities are subject to market risks; read all related documents carefully before investing.